Logo

SENORES PHARMACEUTICALS L Share Price

NSE: SENORES
|
Pharmaceuticals
₹ 1,381.90
+₹45.50 (3.40%)
1D
Last updated 03 Jul, 2026, 15:45 IST

SENORES PHARMACEUTICALS L Share Price Today

As of 5 Jul 2026, SENORES PHARMACEUTICALS L share price is ₹1,381.90. The stock opened at ₹1,350.00, compared to its previous close of ₹1,336.40. During today's trading session, SENORES PHARMACEUTICALS L share price moved in the range of ₹1,332.00 to ₹1,408.00, with an average price of ₹1,370.00 for the day. Looking at its last 52-week, the stock has touched a low of ₹558.55 and a high of ₹1,408.00. On the performance front, SENORES PHARMACEUTICALS L share price has increased by 59.70% over the last six months and is up 141.99% on a year-on-year basis.

₹1,332.00
3.40% up today
₹1,408.00
1D LOW
1D HIGH

SENORES PHARMACEUTICALS L Returns Calculator

Open
₹1,350.00
High
₹1,408.00
Low
₹1,332.00
Prev. close
₹1,336.40
Circuit
L
H
₹1,105.60
₹1,658.20
52-week
L
H
₹558.55
₹1,408.00

SENORES PHARMACEUTICALS L Shareholder Returns

SENORES PHARMACEUTICALS L Share Price History

Mkt Cap Cr
6,152.07
P/E
50.62
P/B
6.59
ROE
12.36%
D/E
0.11
ROCE
14.43%
Div. Yield
0.00%
EPS(TTM)
4.40
Turnover
0.13
EV/EBITDA
28.92
Net Margin
0.00%
Op. Margin
0.00%
ROA
7.58%
Quick Ratio
0.00
Curr. Ratio
5.33
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Senores Pharma. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Senores Pharma. appears overvalued compared to its peers
Step 5 of 5
Earnings
Excellent
Senores Pharma. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,49,048.0039.025.3713.74%0.6117.33%93.240.85%0.5610.90
Divis Laboratories1,77,179.0069.0010.5715.32%0.0019.56%629.490.45%0.5898.19
Torrent Pharmaceuticals1,57,804.0066.0317.0326.76%1.0518.30%16.900.90%0.4964.75
Cipla1,17,642.0025.472.8711.79%0.0015.66%2.891.06%0.4943.52
Dr. Reddy's Laboratories1,12,368.0027.032.9711.07%0.1812.54%375.780.59%0.6338.68
Zydus Lifesciences1,10,651.0021.604.0818.59%0.3117.35%235.250.09%0.3935.38
Lupin1,09,676.0020.484.8923.76%0.0424.88%659.050.75%0.61129.18
Mankind Pharma1,02,729.0053.006.3011.74%0.3413.13%397.020.04%0.5449.37
Aurobindo Pharma90,608.0025.872.399.25%0.1911.76%391.140.26%0.4841.58
Laurus Labs82,398.9060.2610.1018.21%0.4516.70%10.190.20%0.9713.72

SENORES PHARMACEUTICALS L Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹398.25₹214.52₹35.34₹14.17
Other Income₹19.26₹2.82₹3.68₹0.46
Total Revenue₹417.51₹217.34₹39.02₹14.63
Total Expenses₹346.94₹192.40₹26.58₹13.49
Profit Before Tax₹70.57₹24.94₹12.44₹1.14
Tax₹12.23-₹7.77₹4.00₹0.15
Profit After Tax₹58.34₹32.71₹8.43₹0.99
EPS - Basic₹16.12₹13.67₹8.87₹1.81
EPS - Diluted₹16.12₹12.21₹6.65₹1.81

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹70.57₹24.94₹12.44₹1.14
Income before WC changes₹97.68₹42.83₹14.98₹2.23
Change in Assets-₹94.67-₹118.75-₹27.67-₹18.52
Change in Liabilities-₹39.76₹52.70₹13.06₹5.99
Change in WC-₹134.43-₹66.05-₹14.61-₹12.53
Cash flow from Operations-₹45.92-₹25.70-₹1.08-₹10.45
Cash flow from Investing-₹429.48-₹54.23-₹48.29-₹24.44
Cash flow from Financing₹573.13₹86.98₹46.25₹36.46
Total Cash Flow₹97.73₹7.05-₹3.12₹1.58
Cash (Start of the year)₹7.65₹0.10₹3.22₹1.64
Cash (End of the year)₹105.38₹7.65₹0.10₹3.22

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹504.43₹370.97₹79.72₹32.10
Current Assets₹722.43₹250.91₹51.34₹27.05
Total Assets₹1,226.86₹621.88₹131.05₹59.15
Current Liabilities₹240.70₹247.50₹51.88₹9.89
Net Current Asset₹481.73₹3.41-₹0.55₹17.17
Non-Current Liabilities₹173.92₹142.67₹33.67₹12.68
Equity Capital₹812.24₹231.71₹45.50₹36.59
Total Equity & Liabilities₹1,226.86₹621.88₹131.05₹59.15

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹38.54₹34.01₹12.38₹13.54
Other Income₹21.99₹6.84₹6.79₹0.94
Total Revenue₹60.53₹40.85₹19.17₹14.48
Total Expenses₹55.42₹38.82₹17.23₹13.65
Profit Before Tax₹5.11₹2.03₹1.94₹0.83
Tax₹1.42₹1.22₹0.74₹0.15
Profit After Tax₹3.69₹0.81₹1.20₹0.68
EPS - Basic₹1.02₹0.35₹1.26₹1.24
EPS - Diluted₹1.02₹0.32₹0.95₹1.24

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹5.11₹2.03₹1.94₹0.83
Income before WC changes-₹4.79-₹0.56₹3.52₹1.44
Change in Assets-₹20.49-₹24.01-₹16.22-₹30.25
Change in Liabilities₹6.33₹6.50-₹27.09₹4.90
Change in WC-₹14.16-₹17.51-₹43.32-₹25.35
Cash flow from Operations-₹20.40-₹19.26-₹43.41-₹24.06
Cash flow from Investing-₹162.94-₹57.07-₹5.23-₹10.05
Cash flow from Financing₹532.62₹86.68₹47.08₹33.88
Total Cash Flow₹349.28₹10.35-₹1.57-₹0.23
Cash (Start of the year)₹10.44₹0.09₹1.66₹1.64
Cash (End of the year)₹359.72₹10.44₹0.09₹1.41

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹422.02₹245.90₹84.04₹41.19
Current Assets₹412.07₹39.96₹27.68₹13.98
Total Assets₹834.09₹285.86₹111.72₹55.17
Current Liabilities₹41.23₹90.64₹46.79₹8.80
Net Current Asset₹370.84-₹50.68-₹19.11₹5.18
Non-Current Liabilities₹84.89₹27.10₹26.01₹12.68
Equity Capital₹707.97₹168.12₹38.92₹33.69
Total Equity & Liabilities₹834.09₹285.86₹111.72₹55.17
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
1381.9
1001
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 1001
Buy orders: 0%
Sell orders: 100%
Bearish
4
Neutral
2
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
72.79
Bullish
ATR (14)
52.69
Neutral
STOCH(9,6)
83.08
Bearish
STOCH RSI (14)
98.91
Bearish
ADX(9)
46.61
Bearish
UO(9)
48.36
Neutral
ROC(12)
9.92
Bullish
WillR(14)
-16.36
Bearish
Period
Simple value
Exponential vaue
5D
1336.18
1338.67
10D
1312.12
1310.9
20D
1247.32
1256.22
50D
1099.25
1127.55
100D
944.39
1012.31

About SENORES PHARMACEUTICALS L

SENORES PHARMACEUTICALS L logo
ISIN
INE0RB801010
Sector Market Cap
₹ 6,152.07 Cr

Senores Pharmaceuticals Limited is an India-based pharmaceutical company. The Company manufactures products of international quality to cater to the increasing new age demands of the global healthcare industry. The Company's products include Amphetamine Sulfate Tablets USP, 5 mg and 10 mg; Hydroxychloroquine Sulfate Tablets USP, 200 mg; Ketoconazole Tablets USP, 200 mg; Chlorzoxazone Tablets USP, 250 mg; 5Chlorzoxazone Tablets USP, 500 mg; Ketorolac Tromethamine Tablets USP, 10 mg; Diclofenac Potassium Tablets USP, 25 mg; Diclofenac Potassium Tablets USP, 50 mg, and others. It supplies affordable APIs to generic formulations manufacturers. Its product API include Anastrozole, Aripiprazole, Benfotiamine, Clomiphene Citrate, Desloratadine, Desvenlafaxine Succinate, Fluoxetine Hydrochloride, and others. Its domestic portfolio includes Azithromycin for Injection; Meropenem Injection; Ferric Carboxymaltose Injection; Meropenem and Sulbactam for Injection, and others.

SENORES PHARMACEUTICALS L Financial Highlights

  • Revenue: SENORES PHARMACEUTICALS L reported revenue of ₹679.69 crore in FY26 vs ₹417.51 crore in FY25. It showed an increase of 62.80% on a yearly basis.
  • Operating Profit: SENORES PHARMACEUTICALS L reported an operating profit of ₹159.10 crore in FY26 vs ₹70.57 crore in FY25. It showed an increase of 125.45% on a year-on-year basis.
  • Net Profit: SENORES PHARMACEUTICALS L reported a net profit of ₹121.52 crore in FY26 vs ₹58.34 crore in FY25. It showed an increase of 108.30% on a yearly basis.

SENORES PHARMACEUTICALS L Quarterly Result Highlights

  • SENORES PHARMACEUTICALS L reported revenue of ₹192.86 crore in Mar 2026, compared with ₹178.34 crore in Dec 2025, representing an increase of 8.14% on a quarter-on-quarter (QoQ) basis.
  • SENORES PHARMACEUTICALS L reported an operating profit of ₹47.40 crore in Mar 2026, compared with ₹44.60 crore in Dec 2025, representing an increase of 6.28% on a quarter-on-quarter (QoQ) basis.
  • SENORES PHARMACEUTICALS L reported a profit of ₹36.67 crore in Mar 2026, compared with ₹33.58 crore in Dec 2025, reflecting an increase of 9.20% on a QoQ basis.
  • The earnings per share (EPS) of SENORES PHARMACEUTICALS L stood at ₹16.12 during Mar 2026.
Know more
Promoters
45.82%
FII
3.64%
Other DII
4.54%
Retail and other
40.93%
Mutual funds
5.07%
Foreign institutions - FII
Compare against other stocks
SENORES PHARMACEUTICALS L logo
SENORES PHARMACEUTICALS L
Pharmaceuticals
Add Stock
Add Another

FAQs on SENORES PHARMACEUTICALS L Share Price